Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes

FASEB Journal

Volumn 16, Issue 9, 2002, Pages 1041-1049

  Saaristo, Anne ^a   Veikkola, Tanja ^a   Enholm, Berndt ^a   Hytönen, Maija ^c   Arola, Johanna ^b   Pajusola, Katri ^e   Turunen, Päivi ^d   Jeltsch, Michael ^a   Karkkainen, Marika J ^a   Kerjaschki, Dontscho ^f   Bueler, Hansruedi ^e   Ylä Herttuala, Seppo ^d   Alitalo, Kari ^a,g  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e UNIVERSITY OF ZURICH   (Switzerland)

^f UNIVERSITY OF VIENNA   (Austria)

^g Molecular/Cancer Biology Laboratory   (Finland)

Author keywords

Angiopoietin 1; Lymphangiogenesis; VEGF; VEGFR 2; VEGFR 3

Indexed keywords

ADENOVIRUS VECTOR; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN;

ADENOVIRIDAE; ANGIOPOIETIN-1; ANIMALS; BLOOD VESSELS; CAPILLARY PERMEABILITY; CELL LINE; DEPENDOVIRUS; ENDOTHELIAL GROWTH FACTORS; GENETIC VECTORS; LYMPHATIC SYSTEM; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MICE; MICE, NUDE; NASAL MUCOSA; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SKIN; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS;

EID: 0036310244     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-1042com     Document Type: Article

References (43)

1. Vascular growth factors and lymphangiogenesis
2. Regulation of angiogenesis via vascular endothelial growth factor receptors
3. Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D
4. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
5. Role of vascular endothelial growth factor in regulation of physiological angiogenesis
6. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis
7. Isolation of angiopoietin-1, a ligand for the Tie-2 receptor, by secretion-trap expression cloning
8. Vascular-specific growth factors and blood vessel formation
9. Angiopoietin-1 protects the adult vasculature against plasma leakage
10. Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice
11. Missense mutation interfere with VEGFR-3 signalling in primary lympoedema
12. Proteolytic processing regulates receptor specificity and activity of VEGF-C
13. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities
14. Vascular endothelial growth factor C induces angiogenesis in vivo
15. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
16. Presence of VEGF-C and VEGF-D in neuroendocrine cells and their receptor, VEGFR-3 in fenestrated endothelia in human tissues
17. Vascular endothelial growth factor-C and its receptor VEGFR-3 in nasal mucosa and in nasopharyngeal tumors
18. Lymphatic Endothelium: The next frontier of angiogenesis and metastasis research
19. Lymphangiogenesis and tumor metastasis: Myth or reality
20. Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: Role of VEGF-receptor 2 and host VEGF
21. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
22. Adenoviral expression of VEGF-C induces lymphangiogenesis in the skin
23. Beta-galactosidase gene transfer to human malignant glioma in vivo using replicationdeficient retroviruses and adenoviruses
24. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia
25. VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries
26. Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta
27. A model for gene therapy of human hereditary lymphedema
28. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain
29. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells
30. Leakage resistant blood vessels in mice transgenically overexpressing angiopoietin-1
31. Failure of blood island formation and vasculogenesis in Flk-1-deficient mice
32. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3
33. Inhibition of lymphangiogenesis and lympbedema in transgenic mice expressing soluble VEGF receptor-3
34. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis
35. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells
36. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph specific receptor for hyaluronan
37. Leakageresistant blood vessels in mice transgenically overexpressing angiopoietin-1
38. Glomeruloid microvascular proliferation follows adenoviral VPF/VEGF 164 gene delivery
39. Gene therapy in cystic fibrosis
40. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C
41. Adeno-associated virus vectors for gene therapy: More pros than cons
42. Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma
43. VEGF gene therapy: Stimulating angiogenesis or angioma-genesis